Literature DB >> 2994788

Characterization of histamine receptors mediating the stimulation of cyclic AMP accumulation in rabbit cerebral cortical slices.

M Al-Gadi, S J Hill.   

Abstract

The characteristics of histamine-stimulated adenosine 3':5'-cyclic monophosphate (cyclic AMP) accumulation in slices of rabbit cerebral cortex have been investigated. The selective H2-receptor antagonists, cimetidine, tiotidine, metiamide and ranitidine appeared to antagonize the stimulation of cyclic AMP accumulation elicited by histamine in a competitive manner consistent with an interaction with histamine H2-receptors. The H1-receptor antagonist mepyramine (0.8 microM) produced only a weak inhibition of the response to histamine. The inhibition appeared to be non-competitive producing a decrease in the maximal response with little effect on the EC50 value. The specific H2-receptor agonist, impromidine, produced a maximum response of only 31 +/- 2% of that obtained with histamine. Studies with histamine and impromidine in combination indicated that impromidine was not acting as a partial agonist. 2-Thiazolylethylamine, a selective H1-agonist, produced only a weak response (EC50 approximately 1mM) yielding a relative potency with respect to histamine (= 100) of 2.5. In the presence of a supramaximal concentration of impromidine, histamine and 2-thiazolylethylamine further elevated the response to impromidine. In these conditions the relative potency of 2-thiazolylethylamine was increased to 59 (histamine = 100), a value which was comparable with that reported for H1-receptor-mediated contractions of guinea-pig ileum. The H1-receptor antagonists mepyramine, promethazine, triprolidine and chlorpheniramine competitively antagonized the potentiation of impromidine-stimulated cyclic AMP accumulation elicited by histamine and 2-thiazolylethylamine in rabbit cerebral cortex without affecting the response to impromidine alone. (+)-Chlorpheniramine was some 150 fold more potent than the (-)-isomer in this respect. Histamine and adenosine in combination had a much greater than additive effect on the accumulation of cyclic AMP in rabbit cerebral cortical slices. The potentiation of the adenosine response could be partially but not completely antagonized by either cimetidine or mepyramine. In the presence of H2-receptor blockade with 0.02 mM tiotidine, histamine elicited a significant potentiation (EC50 44 microM) of the response to adenosine. This response was antagonized competitively by mepyramine yielding a KB value of 0.05 microM similar to that obtained from inhibition of the potentiation of impromidine-stimulated accumulation of cyclic AMP (0.02 microM). These results suggest that there are two components in the response to histamine in rabbit cerebral cortical slices. The first component appears to be mediated by histamine H2-receptors while the second, mepyramine-sensitive, component has some ofthe characteristics ofan H,-receptor mediated response and requires prior stimulation of adenosine- or H2-receptors to produce its effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994788      PMCID: PMC1916657          DOI: 10.1111/j.1476-5381.1985.tb11087.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Histamine-sensitive adenylate cyclase in mammalian brain.

Authors:  L R Hegstrand; P D Kanof; P Greengard
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

2.  Some chemical and physical properties associated with histamine antagonism.

Authors:  P B MARSHALL
Journal:  Br J Pharmacol Chemother       Date:  1955-09

3.  Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide.

Authors:  J P Green; C L Johnson; H Weinstein; S Maayani
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  Saturation assay for cyclic AMP using endogenous binding protein.

Authors:  B L Brown; R P Ekins; J D Albano
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

5.  Studies on adenosine 3',5'-phosphate in rabbit cerebral cortex.

Authors:  S Kakiuchi; T W Rall
Journal:  Mol Pharmacol       Date:  1968-07       Impact factor: 4.436

6.  Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].

Authors:  J Bradshaw; R T Brittain; J W Clitherow; M J Daly; D Jack; B J Price; R Stables
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

7.  The binding of [3H]mepyramine to histamine H1 receptors in guinea-pig brain.

Authors:  S J Hill; P C Emson; J M Young
Journal:  J Neurochem       Date:  1978-10       Impact factor: 5.372

8.  Characteristics of the catecholamine and histamine receptor sites mediating accumulation of cyclic adenosine 3',5'-monophosphate in guinea pig brain.

Authors:  M Chasin; F Mamrak; G Samaniego; S M Hess
Journal:  J Neurochem       Date:  1973-12       Impact factor: 5.372

9.  Affinities of histamine H1-antagonists in guinea pig brain: similarity of values determined from [3H]mepyramine binding and from inhibition of a functional response.

Authors:  S J Hill; P Daum; J M Young
Journal:  J Neurochem       Date:  1981-11       Impact factor: 5.372

10.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more
  9 in total

1.  The determination of receptor constants for histamine H2-agonists in the guinea-pig isolated right atrium using an irreversible H2-antagonist.

Authors:  T J Rising; A Steward
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

2.  The role of calcium in the cyclic AMP response to histamine in rabbit cerebral cortical slices.

Authors:  M Al-Gadi; S J Hill
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

3.  Histamine dependent cAMP generating system in rabbit CNS: interaction with various neuroregulators.

Authors:  B Sek; A Sebastjanska; J Z Nowak
Journal:  Agents Actions       Date:  1987-04

4.  Acceleration of rat brain beta-adrenoceptor subsensitivity following the coadministration of histamine receptor antagonists with imipramine.

Authors:  A A Alhaider; A A Mustafa
Journal:  Agents Actions       Date:  1989-11

5.  Histamine H1-receptor-mediated inositol phospholipid hydrolysis in DDT1MF-2 cells: agonist and antagonist properties.

Authors:  T E White; J M Dickenson; S J Hill
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

6.  Effects of histamine and betahistine on rat medial vestibular nucleus neurones: possible mechanism of action of anti-histaminergic drugs in vertigo and motion sickness.

Authors:  J J Wang; M B Dutia
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

7.  Interaction between histamine and adenosine in human cerebromicrovascular endothelial cells: modulation of second messengers.

Authors:  D B Stanimirovic; N Bertrand; N Merkel; J Bembry; M Spatz
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

8.  Histamine dependent cyclic AMP generating system in rabbit CNS: interaction with neuroregulators and forskolin.

Authors:  B Sek; A Sebastjanska; J Z Nowak
Journal:  Agents Actions       Date:  1988-04

9.  Histamine H₂ receptor signaling × environment interactions determine susceptibility to experimental allergic encephalomyelitis.

Authors:  Naresha Saligrama; Laure K Case; Dimitry N Krementsov; Cory Teuscher
Journal:  FASEB J       Date:  2013-12-26       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.